Exploring how cigarette marketing affects smoking habits in young adults from different income levels
Understanding How Cigarette Direct Mail Marketing Influence Smoking Behaviors Among High and Low Socioeconomic Status Young Adult Smokers
This study is testing how cigarette ads sent through the mail affect smoking habits in young adults aged 18 to 29 from different income backgrounds.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 530 (estimated) |
| Ages | 18 Years to 29 Years |
| Sex | All |
| Sponsor | National Institutes of Health Clinical Center (CC) NIH |
| Drugs / interventions | radiation |
| Locations | 1 site (Bethesda, Maryland) |
| Trial ID | NCT02974582 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of cigarette direct mail marketing on smoking behaviors among young adults aged 18 to 29, focusing on those from high and low socioeconomic statuses. Participants will undergo a single visit where they will provide health information, undergo vital sign checks, and submit blood and urine samples. They will also participate in an experiment involving exposure to various types of smoking advertisements and complete a self-administered interview to gather sociodemographic and psychosocial data. The study aims to enhance understanding of how marketing influences smoking behavior across different socioeconomic groups.
Who should consider this trial
Good fit: Ideal candidates are current smokers aged 18 to 29, with a history of smoking at least 100 cigarettes and a breath carbon monoxide level above 6ppm.
Not a fit: Patients who do not smoke or are outside the age range of 18 to 29 will not benefit from this study.
Why it matters
Potential benefit: If successful, this research could inform public health strategies to mitigate the impact of cigarette marketing on young smokers.
How similar studies have performed: Previous studies have indicated a need for more comprehensive data on the effects of cigarette marketing, suggesting that this approach is novel and underexplored.
Eligibility criteria
Show full inclusion / exclusion criteria
* INCLUSION CRITERIA: * Age: 18 to 29 years, given our focus on young adults. * Smoking status: Current smokers who report smoking every day and who have smoked at least 100 cigarettes in their lifetime with a breath carbon monoxide level greater than 6ppm per device guidelines * SES: For the purpose of the study, we will use the empirical groups from our analysis of the Current Population Survey -Tobacco Use Supplement data. Two groups are chosen based on their social determinants and prevalence of smoking. 1. Low SES: Young adults who do not have a four-year college degree, are not currently enrolled in a four-year college, were born in the US, and have an annual income less than $50,000. This is the group that has been shown to have the highest prevalence of smoking. 2. High SES: Young adults who are currently enrolled in or graduated from a four year college. This is the group that has been shown to have the lowest prevalence of smoking. * English proficiency: since study materials are available only in English, only participants who are able to understand English and follow instructions in English are to be enrolled. * Cognitive ability: Able to understand and willing to sign a written informed consent document. * General health: Participants need to be generally healthy, as defined as someone with no known significant health problems. Participants can have chronic health conditions if the condition is well managed. EXCLUSION CRITERIA: * Inability, in the judgment of the investigator, to understand and follow the requirements of the protocol. * Currently enrolled in high school. * Participants with eye conditions that restrict their ability to track an object with their eyes. * Participants with myopia, hyperopia, and/or astigmatism who cannot pass a simple vision test even with corrective lenses. * Participants with medical condition(s) that may be triggered by infrared radiation (e.g., epilepsy). * Self-reported use of alcohol, recreational drugs or prescription medications used for recreational purposes (e.g., amphetamines, cannabis, cocaine, MDMA, ketamines, LSD, opiates and opioids, tranquilizers or opioid analgesics) that may influence their judgement at the time of study in the past 12 hours before the study visit. * Participants who cannot see an object located between 15 to 27 inches away from them (the required distance between the computer screen and the participants for accurate eye-tracking), even with corrective contact lenses.
Where this trial is running
Bethesda, Maryland
- National Institutes of Health Clinical Center — Bethesda, Maryland, United States (Recruiting)
Study contacts
- Principal investigator: Kelvin C Choi, Ph.D. — National Institute on Minority Health and Health Disparities (NIMHD)
- Study coordinator: Bambi JE Jewett
- Email: bambi.jewett@nih.gov
- Phone: (301) 827-0493
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.